Precigen, Inc.
General ticker "PGEN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $592.0M (TTM average)
Precigen, Inc. follows the US Stock Market performance with the rate: 48.9%.
Estimated limits based on current volatility of 2.3%: low 3.43$, high 3.60$
Factors to consider:
- Total employees count: 190 (-9.1%) as of 2023
- Countries other than US accounted for 0.0% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Product development risks, Capital raising, Operational and conduct risks, Labor/talent shortage/retention, IT system failures
- Current price 171.4% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.53$, 1.38$]
- 2025-12-31 to 2026-12-31 estimated range: [0.48$, 1.24$]
Financial Metrics affecting the PGEN estimates:
- Positive: with PPE of -2.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -31.61 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: -14.38 < Investing cash flow per share per price, % of -9.60
- Positive: 18.93 < Shareholder equity ratio, % of 26.51 <= 41.86
- Positive: Inventory ratio change, % of -5.49 <= -0.75
Short-term PGEN quotes
Long-term PGEN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $26.91MM | $6.22MM | $3.92MM |
| Operating Expenses | $102.64MM | $105.98MM | $138.95MM |
| Operating Income | $-75.73MM | $-99.76MM | $-135.03MM |
| Non-Operating Income | $-4.24MM | $3.40MM | $7.00MM |
| Interest Expense | $6.77MM | $0.47MM | $0.01MM |
| R&D Expense | $47.17MM | $48.61MM | $53.07MM |
| Income(Loss) | $-79.97MM | $-96.36MM | $-128.03MM |
| Taxes | $-0.19MM | $-0.46MM | $-1.79MM |
| Other Income(Loss) | $108.09MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $136.41MM | $-95.90MM | $-126.23MM |
| Stockholders Equity | $126.26MM | $118.50MM | $38.51MM |
| Inventory | $0.29MM | $0.00MM | $0.00MM |
| Assets | $215.98MM | $151.04MM | $145.27MM |
| Operating Cash Flow | $-65.05MM | $-66.93MM | $-68.17MM |
| Capital expenditure | $4.92MM | $1.54MM | $8.58MM |
| Investing Cash Flow | $226.42MM | $-3.09MM | $-20.71MM |
| Financing Cash Flow | $-155.29MM | $29.59MM | $110.58MM |
| Earnings Per Share** | $0.68 | $-0.39 | $-0.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.